BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23117580)

  • 21. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity.
    Lubecka K; Kurzava L; Flower K; Buvala H; Zhang H; Teegarden D; Camarillo I; Suderman M; Kuang S; Andrisani O; Flanagan JM; Stefanska B
    Carcinogenesis; 2016 Jul; 37(7):656-68. PubMed ID: 27207652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.
    Vesuna F; Lisok A; Kimble B; Domek J; Kato Y; van der Groep P; Artemov D; Kowalski J; Carraway H; van Diest P; Raman V
    Oncogene; 2012 Jul; 31(27):3223-34. PubMed ID: 22056872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epigenetic mechanism mediates developmental nicotine effects on neuronal structure and behavior.
    Jung Y; Hsieh LS; Lee AM; Zhou Z; Coman D; Heath CJ; Hyder F; Mineur YS; Yuan Q; Goldman D; Bordey A; Picciotto MR
    Nat Neurosci; 2016 Jul; 19(7):905-14. PubMed ID: 27239938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-Regulation of H3K4me3 by MM-102 Facilitates Epigenetic Reprogramming of Porcine Somatic Cell Nuclear Transfer Embryos.
    Zhang Z; Zhai Y; Ma X; Zhang S; An X; Yu H; Li Z
    Cell Physiol Biochem; 2018; 45(4):1529-1540. PubMed ID: 29466785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
    Chatterjee B; Ghosh K; Kanade SR
    Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genes upregulated in the amnion at labour are bivalently marked by activating and repressive histone modifications.
    Mitchell CM; Hirst JJ; Mitchell MD; Murray HG; Zakar T
    Mol Hum Reprod; 2019 Apr; 25(4):228-240. PubMed ID: 30753586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
    Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
    Estève PO; Chin HG; Pradhan S
    J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H1 linker histone promotes epigenetic silencing by regulating both DNA methylation and histone H3 methylation.
    Yang SM; Kim BJ; Norwood Toro L; Skoultchi AI
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1708-13. PubMed ID: 23302691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.
    Sun L; Huang L; Nguyen P; Bisht KS; Bar-Sela G; Ho AS; Bradbury CM; Yu W; Cui H; Lee S; Trepel JB; Feinberg AP; Gius D
    Cancer Res; 2008 Apr; 68(8):2726-35. PubMed ID: 18413740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.
    Peng L; Yuan Z; Ling H; Fukasawa K; Robertson K; Olashaw N; Koomen J; Chen J; Lane WS; Seto E
    Mol Cell Biol; 2011 Dec; 31(23):4720-34. PubMed ID: 21947282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
    Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis.
    Montenegro MF; Sánchez-Del-Campo L; González-Guerrero R; Martínez-Barba E; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
    Oncogene; 2016 Nov; 35(47):6143-6152. PubMed ID: 27132511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.
    Erfani P; Tome-Garcia J; Canoll P; Doetsch F; Tsankova NM
    Epigenetics; 2015; 10(6):496-507. PubMed ID: 25996283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
    Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
    Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASH2L, a COMPASS core subunit, is involved in the cell invasion and migration of triple-negative breast cancer cells through the epigenetic control of histone H3 lysine 4 methylation.
    Batbayar G; Ishimura A; Lyu H; Wanna-Udom S; Meguro-Horike M; Terashima M; Horike SI; Takino T; Suzuki T
    Biochem Biophys Res Commun; 2023 Aug; 669():19-29. PubMed ID: 37262949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.